Journal of Osteoporosis / 2012 / Article / Tab 2

Research Article

Association between P2X7 Receptor Polymorphisms and Bone Status in Mice

Table 2

Bone parameters and concentration of in vivo bone markers presented as means (±SD). Number of animals in each strain is indicated at the top of the table ( 𝑛 ). BMD, BMC, and bone area, in whole body or femoral region was determined by DXA scanning. An electronic digital caliper measured femoral length, before bone strength of the femur was determined by a 3-point bending test. In vivo bone markers were measured on serum using commercial available kits. One-way ANOVA was performed to test differences between groups and post hoc Bonferroni corrections, using 0.05 as the significance level. Simple descriptive of data is presented as means and standard deviations (SD). Significant difference between the 129X1/SvJ, BALB/cJ, B6, and DBA/2 animals at the 𝑃 < 0 . 0 5 level is extracted from Bonferroni multiple comparison analysis and indicated with asterisks when different from the three other strains, with A when different from 129X1/SvJ, with B when different from B6, with C when different from BALB/cJ, and with D when different from DBA/2J.

Sample size ( 𝑛 )129X1/SvJBALB/cJB6DBA/2JSWR/JC57L/JAKR/JSJL/JNZB/BlNJC3H/HeJANOVA one way
15141614141515151515
P451L genotypePPLLLLLLLL

Bone Parameters
 BMD (g/cm2)0.0562*0.0513A, D0.0502A, D0.0468*0.04770.05790.05760.05480.05250.0563<0.001
(±0.0020)(±0.0018)(±0.0020)(±0.0022)(±0.0013)(±0.0030)(±0.0021)(±0.0015)(±0.0041)(±0.0018)
 BMC (g)0.535*0.471A, D0.458A, D0.358*0.3940.5480.5930.4590.4650.558<0.001
(±0.045)(±0.028)(±0.031)(±0.029)(±0.035)(±0.042)(±0.046)(±0.025)(±0.064)(±0.036)
 Area (cm2)9.53D9.19D9.13D7.65*8.269.4610.298.388.839.90<0.001
(±0.53)(±0.30)(±0.40)(±0.41)(±0.54)(±0.35)(±0.60)(±0.40)(±0.60)(±0.50)
 BMD in femur region (g/cm2)0.0798B, D0.0764B, D0.0655A, C0.0639A, C0.06500.07860.07820.07740.07400.0826<0.001
(±0.0039)(±0.0021)(±0.0033)(±0.0028)(±0.0024)(±0.0049)(±0.0036)(±0.0032)(±0.0052)(±0.0037)
 BMC in femur region (g)0.0439B,D0.0402D0.0364A, D0.0281*0.03070.04640.04660.03910.03780.0439<0.001
(±0.0044)(±0.0028)(±0.0026)(±0.0026)(±0.0021)(±0.0044)(±0.0029)(±0.0030)(±0.0060)(±0.0036)
 Area of femur region (cm2)0.552D0.529D0.558D0.443*0.4760.5950.5990.5070.5110.533<0.001
(±0.035)(±0.031)(±0.027)(±0.035)(±0.031)(±0.046)(±0.026)(±0.032)(±0.053)(±0.028)
 Femur length (mm)15.25D15.06D15.53D14.34*14.2915.7916.0014.0815.9015.61<0.001
(±0.36)(±0.64)(±0.23)(±0.45)(±0.40)(±0.33)(±0.69)(±0.28)(±0.45)(±0.64)
 Strength/Max. load femurs ( 𝑁 )31.5*24.6*16.3A, C18.7A, C16.728.030.520.023.333.9<0.001
(±3.2)(±1.7)(±1.1)(±1.5)(±0.8)(±2.4)(±2.8)(±0.8)(±3.0)(±2.3)

In vivo bone markers
 Osteocalcin (ng/mL)40.0C, D55.91*38.42C, D71.72*38.4436.4972.3751.0948.4963.22<0.001
(±9.48)(±11.78)(±11.11)(±10.89)(±8.97)(±8.75)(±11.25)(±10.20)(±8.06)(±11.38)
 ALP (nmol/mL)266.8314.2260.2317.6272.5179.7190.9213.7299.4270.6<0.001
(±56.1)(±41.2)(±63.8)(±60.5)(±39.9)(±48.3)(±62.5)(±59.6)(±36.3)(±56.3)
 RatLaps-Telopeptide collagen (ng/mL)14.28B,C19.09*9.81A, C12.13C10.759.377.077.158.838.76<0.001
(±3.45)(±4.40)(±1.86)(±1.88)(±1.62)(±2.53)(±2.62)(±1.83)(±1.95)(±4.02)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.